Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

cannon5974

Rank: Mail Room [?]

Points: 44 [?]

Votes: 2 Score: 2.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

in response to

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

liahall

posted on Mar 27, 2013 02:33PM

Yes, I agree. With 2.5B in annual Revenue; the stock price should easily be between $15-$20/share, which would put the market cap between $6-$8B.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply